Cutaneous eruptions in patients receiving immune checkpoint blockade: clinicopathologic analysis of the nonlichenoid histologic pattern
GJ Kaunitz, M Loss, H Rizvi, S Ravi… - The American journal …, 2017 - journals.lww.com
Cutaneous eruptions are among the most common immune-related adverse events (irAEs)
associated with anti-programmed cell death protein 1/programmed cell death ligand 1
therapy, and are often clinically and histologically characterized as lichenoid. Nonlichenoid
patterns may also occur and are likely to be encountered by surgical pathologists, given the
increasing clinical use of these agents. The purpose of this study is to describe the
histopathologic features of nonlichenoid cutaneous irAEs from patients receiving anti …
associated with anti-programmed cell death protein 1/programmed cell death ligand 1
therapy, and are often clinically and histologically characterized as lichenoid. Nonlichenoid
patterns may also occur and are likely to be encountered by surgical pathologists, given the
increasing clinical use of these agents. The purpose of this study is to describe the
histopathologic features of nonlichenoid cutaneous irAEs from patients receiving anti …